Pricing in Hearing Healthcare: Which Race are You Running? Part 3 – Implications of Health Insurance on Consumer Demand

by Amyn M Amlani, PhD Today’s blog, Part 3, is the last in the series, “Pricing in Hearing Healthcare: Which Race are You Running?” Thus far, we have covered the: Developing market segmentation occurring in hearing healthcare (Part 1), and the Negative effect (i.e., cannibalization) of reduced retail pricing on total revenue, consumer purchase intent,…

Read More
audiology reimbursement medicare

Over-the-Counter Hearing Aids as a Catalyst for Audiology Reimbursement Updates

Dear Readers: During this holiday season, the editors at Hearing Health & Technology Matters (HHTM) are taking some time off. However, we are not leaving you without anything to read on our blog this week. Instead, we are publishing a special holiday edition filled with what we call our Readers’ Choices. Our Readers’ Choices featured…

Read More
pricing audiology private practice

Pricing in Hearing Healthcare: Which Race are You Running? Part 2 – Consequences of Reduced Retail Pricing

by Amyn M Amlani, PhD In Part 1 of the series on “Pricing in Hearing Healthcare: Which Race are You Running?,” the reader was provided with an overview of the supply-side’s strategy to reduce retail prices to encourage product uptake/adoption. Such a strategy, it was contended, supported the transition of hearing healthcare from a predominately…

Read More
practice management pricing

Pricing in Hearing Healthcare: Which Race are You Running? Part 1 – Market Segmentation

by Amyn M Amlani, PhD In hearing healthcare, price continues to be a hot-button topic of discussion among consumers, providers, advocacy groups, legislators, professional organizations, and manufacturers of consumer electronic products and traditional hearing aids. The fundamental issue is that consumers and their supporters believe the costs associated with and the value received in treating…

Read More
treat mild hearing loss emerging technology

Evidence of Emerging Technologies as a Treatment Option for Mild-to-Moderate Hearing Loss

by David Maidment, PhD In August 2017, President Trump signed into law the Food and Drug Administration (FDA) Reauthorization Act, which included the Over-the-Counter (OTC) Hearing Aid Act. The primary intention of the Act is to improve accessibility and affordability to hearing healthcare in adults with mild to moderate hearing loss. The FDA has one…

Read More